Chiropractic Treatment With Counseling Versus Counseling Alone for Promoting Smoking Cessation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01689168|
Recruitment Status : Terminated (Funding ran out)
First Posted : September 21, 2012
Last Update Posted : May 20, 2015
Tobacco use is the number one killer of Americans today. Most current smokers have tried and failed to quit at least once. Smokers are addicted to the nicotine in tobacco products, and withdrawal from smoking can lead to physical symptoms such as irritability, anxiety, nervousness, depression and insomnia.
This study will examine the effects of tobacco cessation counseling and chiropractic treatments on smokers who desire to quit.
|Condition or disease||Intervention/treatment||Phase|
|Smoking||Behavioral: Counseling Procedure: Chiropractic adjustment||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||19 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Chiropractic Treatment With Counseling Versus Counseling Alone for Promoting Smoking Cessation: A Randomized Clinical Trial|
|Study Start Date :||March 2012|
|Actual Primary Completion Date :||December 2013|
|Actual Study Completion Date :||May 2014|
|Experimental: Counseling plus chiropractic adjustments||
Tobacco cessation counselingProcedure: Chiropractic adjustment
Full spine high velocity, low amplitude manipulation of the spine
|Active Comparator: Counseling alone||
Tobacco cessation counseling
- Tobacco cessation [ Time Frame: Smoking diary will be complete for 3 months ]Has the subject quit smoking?
- Urinary cotinine [ Time Frame: Baseline, 14, 30, 60 and 90 days ]An urinary test for nicotine metabolites
- Blood pressure [ Time Frame: Baseline, 14, 30, 60 days ]
- Weight [ Time Frame: Baseline, 14, 30, 60 days ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01689168
|United States, California|
|University Health Center - Whittier|
|Whittier, California, United States, 90604|
|Principal Investigator:||Kevin A Rose, DC, MPH||Southern California University of Health Sciences|